Monday 5 March 2018 photo 4/15
![]() ![]() ![]() |
Mynx closure device instructions for use: >> http://wja.cloudz.pw/download?file=mynx+closure+device+instructions+for+use << (Download)
Mynx closure device instructions for use: >> http://wja.cloudz.pw/read?file=mynx+closure+device+instructions+for+use << (Read Online)
mynx vascular closure device mri safety
mynx vascular closure device
mynx closure device complications
mynx closure device patient information
mynx closure device swelling
mynxgrip closure device mri safety
mynx ace vascular closure device
mynx closure device after care
read all information contained in these instructions for use. DEVICE DESCRIPTION. The Mynx Ace Vascular Closure Device (Mynx Ace) is designed to achieve femoral artery hemostasis via delivery of Grip Technology, an extravascular, water-soluble synthetic sealant, using a balloon catheter in conjunction with a custom
2 Oct 2013 Mynx Vascular. Closure Device. Early Ambulation Study. Vascular closure devices (VCDs) are increasingly used for femoral access closure in cardiac cath- . Device success was defined as successful deployment of the. Mynx device and hemostasis achieved with no more than 10 minutes of manual
INSTRUCTIONS FOR USE - MynxGrip Vascular Closure Device. LBL9288.B MODEL MX6721 and MX5021. 7. POTENTIAL ADVERSE EVENTS. In addition to the complications noted in the Mynx clinical trial, the following potential complications, which may be related to the endovascular procedure or the vascular closure
13 Dec 2013
since such a puncture site may result in a retroperitoneal hematoma/bleed. Perform a femoral angiogram or venogram to verify the location of the puncture site. Do not use the. MYNXGRIP® Device if the puncture is through the posterior wall or if there are multiple punctures, as such punctures may result in a retroperitoneal.
After closure, the access site was assessed for hemostasis. Device success was defined as successful deployment of the Mynx device and hemostasis achieved with no more than 10 minutes of manual compression. Patients were ambulated 1 hour after Mynx deployment, and the time to ambulation and dischargeability
23 May 2017
Pick up device handle and realign with the tissue tract. Slide back button #3. This pulls the deflated balloon into the device. Insert catheter tip into valve of introducer, penetrate valve with sealant sleeve, and continue to advance until connector prongs on device handle lock into the introducer.
The Grip Technology sealant effectively grips the artery and provides secure extravascular closure. Remove the Device Deflate the balloon and remove the device, leaving nothing behind but a healed artery. The sealant resorbs within 30 days. Refer to the IFU for detailed procedure steps. The MYNXGRIP® Vascular
17 Dec 2013
Annons